Africure Pharmaceuticals Ltd (AFRP.mu) Q12023 Interim Report
Africure Pharmaceuticals Ltd (AFRP.mu) listed on the Stock Exchange of Mauritius under the Pharmaceuticals sector has released it’s 2023 interim results for the first quarter.
For more information about Africure Pharmaceuticals Ltd (AFRP.mu) reports, abridged reports, interim earnings results and earnings presentations visit the Africure Pharmaceuticals Ltd (AFRP.mu) company page on AfricanFinancials.
Africure Pharmaceuticals Ltd 2023 interim results for the first quarter
Company Profile
Africure Pharmaceuticals Ltd is a manufacturer and distributor of high quality essential medication in Africa. It was incorporated on 17 March 2017 and holds a Global Business Licence issued by the Financial Services Commission. The principal activity of the Company is investment holding, trading & procurement of pharmaceutical products. Africure Pharmaceuticals Ltd is listed on the Stock Exchange of Mauritius
Recent Documents & News
-
Interim Reports
Africure Pharmaceuticals Ltd (AFRP.mu) Q32024 Interim Report – February 26, 2024 -
Articles
Africure Pharmaceuticals Ltd: The company has reached 66% of its projected revenue and 63% of its estimated profitability for H1 September 2023-2024. – December 13, 2023 -
Annual Reports
Africure Pharmaceuticals Ltd (AFRP.mu) 2023 Annual Report – December 1, 2023 -
Interim Reports
Africure Pharmaceuticals Ltd (AFRP.mu) HY2024 Interim Report – November 22, 2023 -
Articles
Africure Pharmaceuticals Ltd Achieves 70% of Budgeted Revenue in Q1 2024 with Revenues at USD 6.57 Mn – September 6, 2023